User:Mr. Ibrahem/Gadopiclenol

Gadopiclenol, sold under the brand name Elucirem, is a contrast agent used in magnetic resonance imaging (MRI) to detect lesions with abnormal blood vessels. It may be used in those who are at least two years old. It is given by injection into a vein.

Common side effects include pain at the site of injection, headache, nausea, and dizziness. Other side effects may include nephrogenic systemic fibrosis, allergic reactions, and retention of gadolinium. Safety in pregnancy is unclear. It is a paramagnetic macrocyclic non-ionic complex of gadolinium.

Gadopiclenol was approved for medical use in the United States in 2022. As of 2022 it is being looked at the approval agency in Europe.